HLA Typing B51 Locus in Parel
50+ booked in last 3 daysHla B51 Test Overview
HLA B51 Locus in blood refers to a specific genetic marker associated with autoimmune conditions, such as Behçet's disease. Testing for HLA B51 helps identify genetic predispositions and aids in disease diagnosis and management. By identifying the HLA-B51 status of both parties, medical professionals can increase the likelihood of finding a compatible donor with closely matching HLA antigens, thus reducing the risk of organ rejection.
HLA Typing B51 Locus Price in Parel
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the HLA Typing B51 Locus with a clear pricing structure
The price of HLA Typing B51 Locus in Parel is ₹ 9,435
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Human leukocyte antigen (HLA)-B5 and HLA- B51 genes are important in the pathogenesis of a disease. Positive result in the HLA- B51 test indicates increase in the risk for Behcet's disease by six times.
For the patients who are at risk for Behcet's disease.
Behçet disease is a vasculitic disorder defined by the presence of recurrent oral ulcers, genital ulcers, eye disease (characteristically uveitis), and skin lesions. Risk of developing the disease is associated with being a carrier of the HLA-B51 & HLA-B5 allele.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.